Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 108 Triple Negative Breast Neoplasms 27 Neoplasm Metastasis 17 Sarcoma 16 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 7 Ovarian Neoplasms 6 Brain Neoplasms 5 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Liposarcoma 3 Inflammatory Breast Neoplasms 3 HER2-negative Breast Cancer 3 Carcinoma, Transitional Cell 3 Urethral Neoplasms 2 Ureteral Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Melanoma 2 Lymphoma 2 Lung Neoplasms 2 Leiomyosarcoma 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma 2 Advanced Breast Cancer 2

Interventions

eribulin 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brest Cancer × eribulin × Clear all

NCT07333937 2026-01-12

NETHER

Xijing Hospital

Phase 2 Not yet recruiting

Brest Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡